These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16803684)

  • 1. Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype.
    Amano Y; Kushiyama Y; Yuki T; Takahashi Y; Moriyama I; Fukuhara H; Ishimura N; Furuta K; Ishihara S; Adachi K; Maruyama R; Kinoshita Y
    Scand J Gastroenterol; 2006 Aug; 41(8):873-9. PubMed ID: 16803684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy.
    Amano Y; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Ishimura N; Furuta K; Ishihara S; Adachi K; Maruyama R; Kinoshita Y
    J Gastroenterol Hepatol; 2007 Jun; 22(6):901-7. PubMed ID: 17565646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's esophagus: a discrepancy between macroscopic and histological diagnosis.
    Endlicher E; Rümmele P; Beer S; Knüchel R; Rath H; Schlottmann K; Grossmann J; Woenckhaus U; Schölmerich J; Messmann H
    Endoscopy; 2005 Nov; 37(11):1131-5. PubMed ID: 16281145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective multivariate analysis of factors predictive of complete regression of Barrett's esophagus.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3420-6. PubMed ID: 10606297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REG Ialpha protein expression in Barrett's esophagus.
    Chinuki D; Amano Y; Ishihara S; Moriyama N; Ishimura N; Kazumori H; Kadowaki Y; Takasawa S; Okamoto H; Kinoshita Y
    J Gastroenterol Hepatol; 2008 Feb; 23(2):296-302. PubMed ID: 18289358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage.
    Amano Y; Ishihara S; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Miyake T; Miyaoka Y; Rumi MA; Ishimura N; Adachi K; Kinoshita Y
    Aliment Pharmacol Ther; 2004 Oct; 20(7):793-802. PubMed ID: 15379840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of modified crystal violet chromoendoscopy procedure using new mucosal pit pattern classification for detection of Barrett's dysplastic lesions.
    Yuki T; Amano Y; Kushiyama Y; Takahashi Y; Ose T; Moriyama I; Fukuhara H; Ishimura N; Koshino K; Furuta K; Ishihara S; Adachi K; Kinoshita Y
    Dig Liver Dis; 2006 May; 38(5):296-300. PubMed ID: 16542886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's esophagus: prevalence and size of hiatal hernia.
    Cameron AJ
    Am J Gastroenterol; 1999 Aug; 94(8):2054-9. PubMed ID: 10445527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mucin-2 and correlation with PAS-alcian blue stain in Barrett's esophagus.
    Lopes CV; Pereira-Lima J; Hartmann A
    Hepatogastroenterology; 2006; 53(70):511-5. PubMed ID: 16995451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histochemical diagnosis of short segment Barrett's esophagus].
    Fujiyama Y; Ishizuka I; Koyama S
    Nihon Rinsho; 2005 Aug; 63(8):1420-6. PubMed ID: 16101233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between symptomatic gastroesophageal reflux and Barrett's esophagus].
    Trujillo-Benavides OE; Baltazar-Montúfar P; Angeles-Garay U; Ramírez-Mendoza P; Navarro-García AM; Paredes-Cruz E; Méndez del Monte R; Guerrero-Hernández M
    Rev Gastroenterol Mex; 2005; 70(1):14-9. PubMed ID: 16170957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal violet chromoendoscopy with mucosal pit pattern diagnosis is useful for surveillance of short-segment Barrett's esophagus.
    Amano Y; Kushiyama Y; Ishihara S; Yuki T; Miyaoka Y; Yoshino N; Ishimura N; Fujishiro H; Adachi K; Maruyama R; Rumi MA; Kinoshita Y
    Am J Gastroenterol; 2005 Jan; 100(1):21-6. PubMed ID: 15654776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
    Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
    Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy.
    Veldhuyzen van Zanten SJ; Thomson AB; Barkun AN; Armstrong D; Chiba N; White RJ; Escobedo S; Sinclair P
    Aliment Pharmacol Ther; 2006 Mar; 23(5):595-9. PubMed ID: 16480398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short segment Barrett's esophagus: relationship of age with extent of intestinal metaplasia.
    Benipal P; Garewal HS; Sampliner RE; Martinez P; Hayden CW; Fass R
    Am J Gastroenterol; 2001 Nov; 96(11):3084-8. PubMed ID: 11721753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy.
    Eloubeidi MA; Provenzale D
    Am J Gastroenterol; 1999 Apr; 94(4):937-43. PubMed ID: 10201460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the clinical significance of stromal angiogenesis in Barrett's esophagus?
    Moriyama N; Amano Y; Mishima Y; Okita K; Takahashi Y; Yuki T; Ishimura N; Ishihara S; Kinoshita Y
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S210-5. PubMed ID: 19120900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms.
    Toruner M; Soykan I; Ensari A; Kuzu I; Yurdaydin C; Ozden A
    J Gastroenterol Hepatol; 2004 May; 19(5):535-40. PubMed ID: 15086597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.